24 May 2013
Keywords: infinity, pharma, signs, deal, novartis, develop, bcl-2
Article | 13 March 2006
US drugmaker Infinity Pharmaceuticals, a specialist developer of innovative anticancer drugs, says it has entered into a global strategic
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
13 March 2006
23 May 2013
© 2013 thepharmaletter.com